Conference
Antitumor activity of bortezomib (PS-341; Velcade) in a phase II study of patients with previously untreated or treated Waldenstrom's macroglobulinemia (WM)
Authors
Chen CI; White D; Kouroukis CT; Stewart AK; Howson-Jan K; Larratt L; Powers J; Eisenhauer E
Volume
104
Pagination
pp. 896A-896A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2004
Name of conference
46th Annual Meeting of the American-Society-of-Hematology
Conference place
San Diego, CA
Conference start date
December 4, 2004
Conference end date
December 7, 2004
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971